Compared to the known NSCLC biomarker CYFRA 21-1, HMGB1 demonstrated similar diagnostic value in terms of ROC curves and comparable prognostic value with respect to stratification of overall survival using Kaplan–Meier curves. This evidence concerns the gene HMGB1 and non-small cell lung carcinoma.